Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Medical Journal of Clinical Trials & Case Studies Research Article 8 min read

Biochemical Studies of Tuberclosis and HIV Cases in Parts of Abia, Anambra and Imo States

Cletus OE, Nwachukwu NC, Elendu CO and Johnkennedy N*
* Corresponding author
ISSN: 2578-4838  10.23880/mjccs-16000288  Received: April 16, 2021  Published: May 25, 2021
  views
 19 references
 5 tables
PDF
Keywords
Biochemical Tuberclosis HIV Cases Abia Anambra Imo
Abstract

Aim: The biochemical of tuberculosis (TB) and (HIV) patients in parts of Abia, Anambra and Imo States, were carried out using, standard biochemical procedures. Methods: Two hospitals were chosen from each of the three States, namely: St. Charles Borromeo Specialist Hospital Onitsha and Nnamdi Azikiwe University Teaching Hospital (NAUTH) Nnewi, Federal Medical Centre (FMC) Umuahia and Abia State University Teaching Hospital (ABSUTH) Aba, and Federal Medical Centre (FMC) Owerri and Imo State University Teaching Hospital (IMSUTH) Orlu from January 2013 to December 2014. . The biochemical parameters analyzed were glutathione peroxidase (GPX), Vit. C, Vit. E, Uric acid, Malondialdehide (MDA), total cholesterol, triglyceride, HDL – cholesterol, LDLcholesterol, Urea, creatinine, Na+, K+, Cl-, and HC03 in HIV patients (n=50:M=20; F = 30) and in PTB patients (n=50: M=30; F = 20) newly diagnosed (untreated) adults of 18years and above compared with apparently normal (control) individuals who are HIV and PTB seronegative of the same age range, location and n=50: M=20; F = 30 in each of the six selected hospitals in Abia, Anambra and Imo States. Results: The results showed significantly increased concentrations of MDA and Uric acid (P<0.05) and significantly reduced concentrations of Vit. C Vit E and GPX (P<0.05) both in TB patients and HIV patients when compared with the control subjects. It equally revealed significantly increased Urea in all the selected hospitals and reduced Na+ concentration(ABSUTH) (P<0.05) in HIV patients when compared with the control subjects, while creatinine, Cl- and HC03- mean differences were not significant when compared with the control subjects (P>0.05). PTB patients revealed significantly increased Na+, decreased K+, increased Cl-, and decreased HC03- and urea (P<0.05) when compared with the control subjects while mean difference of creatinine though elevated was not statistically significant (P>0.05). Also revealed were significantly reduced concentrations of total cholesterol, triglyceride, HDL and LDL – Cholesterols in PTB patients (P<0.05) when compared with their control subjects. Similar trends were observed in HIV positive patients except that concentration of triglyceride was significantly increased (P<0.05) when compared with the control subjects. Conclusion: Electrolyte imbalance was observed among the patients which equally exposes them to other health problems such as irregular heartbeat, numbness and high blood pressure among other diseases coupled with high level of lipid peroxidation which has been observed playing role in atherosclerosis, ischemia-reperfusion, heart failure, Alzheimer’s disease, rheumatic arthritis, cancer, and other immunological disorders. Meanwhile, there is likelihood of severe oxidative stress due to observed antioxidant depletion that further exposes the patients to Cancer and cardiovascular diseases (CVD. Therefore, decreasing the formation of lipid peroxidation products and balancing the electrolytes and antioxidants could be beneficial in limiting all the deleterious pathological conditions so as to guarantee their good health.

Introduction

Public health, a collective action to improve the health of the members of a community. Epidemiology is a tool for improving public health. Epidemiological, biochemical and histological studies of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) have become necessary in parts of Abia, Anambra and Imo states due to the luming burden of health and economic hardship these diseases have placed on countries in sub Saharan Africa like Nigeria that is already battling with dwindling health and economic situation. The effect of prevention and control program of Tuberculosis in Nigeria is slow [1]. TB-HIV co-infection which have worsened the situation of carriers and tremendously encouraged the spread of the disease which according to WHO has led to a sharp increase of TB infected patients in Nigeria. Nigeria is ranking 4th in terms of incidence [2]. WHO 2010 report that more than 2 billion people (about one third of the world population). With Sub Saharan Africa having highest prevalence. TB-HIV co-infection has highest prevalence in sub Saharan Africa [3]. It will interest you to know that from 1990 to 2011, 34 million people have been infected and are living with HIV worldwide. 23.5 million live in sub Saharan Africa [4]. From the obvious points above, Nigeria and her citizens are not exempted from the attack of these dangerous and contagious diseases. Enormous pathological changes accompany the infection of these two diseases in body chemistry and cells of infected individuals, hence, the biochemical (Antioxidants, Electrolytes, Urea and Creatinine and Lipid profile) and histological studies (Sputum cytology) in addition to the epidemiological survey became necessary with a view to informing the NTBLCP and NACA the target areas that may need quick intervention both in strategy and process and to update the care givers of these patients on the necessary changes that may be occurring in their body which will guide them in their management decisions [5].

In the light of this, this study is done to determine the attendant biochemical statuses of HIV cases (patients) with a view to generating pieces of information that will lead to the positive repositioning of the management and control of these two dangerous contagious diseases in parts of Abia, Anambra, and Imo States.

Materials And Methods

Subjects: A total of 600 confirmed TB (M-30, F-20) and HIV (M-20, F-30) positive subjects/Patients 18 years and above and 50 apparently normal (controls) subjects (M-30, F-20) were randomly selected from six hospitals (IMSUTH Orlu, FMC Owerri, NAUTH Nnewi, St Charles Borromeo Hospital Onitsha, FMC Umuahia and ABSUTH Aba) to participate in the study. i.e. 50 subjects/patients from each of the six selected hospitals in the three states respectively. All of them were fully informed of the details of the research work and consent was obtained prior to the study.

Participation was voluntary and questionnaire was issued to obtain demographic information of the participants such as age, sex, marital status and occupation. Ethical approval for the study was obtained from the ethical committees of the hospitals.

Blood Sample Collection: 10ml hypodermic syringe and needle was used to collect 10ml of whole blood from each TB and HIV positive patients from the dorsal vein using standard clean venipuncture technique and were transferred into pre- labeled lithium heparin tubes. The blood specimens were used for the estimation of the biochemical parameters using standard operating procedures (SOPs) approved by Clinical and Laboratory Standards Institute (CLSI) (formerly known as NCCLS).

Biochemical assay: Urea was determined by Diacetyl monoxime method, Creatinine (Jafee Slot Method), Glutathione Peroxidase, Vitamine C, Vitamin E, MDA and uric acid according to electrolytes (ise, comparative method (humalyte) bicarbonate (phosphoenol pyruvate carboxylase method. TC, TG, HDL-C, LDL-C were determined using colorimetric enzymatic methods [6, 7, 8, 9, 10, 11, 12].

Statistical analysis

Data generated from this study were analyzed using simple percentages, frequency tables, student’s t-test and analysis of variance (ANOVA). Each result was expressed as mean +/- SD. Each of the parameters analyzed was compared with control. Significance of mean differences

Results

were determined using SPSS Version 20 and was accepted at p < 0.05. Pearson’s correlation coefficient was determined at 5% level of significance.

ControlST CHARLESIMSUTHABSUTHFMCUNauthFMCOP Value
VIT C1.44±0.1850.688±0.1190.801±0.2450.849±0.2530.771±0.1800.801±0.1550.803±0.1740.000*
VIT E1.22±0.2740.634±0.1560.592±0.2060.638±0.2290.559±0.1400.579±0.1400.604±0.1630.000*
GPX32.27±9.32120.61±2.52921.26±2.33921.58±2.62620.784±2.62521.524\2.74721.604±2.6310.000*
UA4.44±0.9254.790±0.8595.406±1.0135.430±1.0874.824±0.8585.348±1.0485.386±1.1580.000*
MDA1.68±0.7997.251±1.1252.17±1.0052.882±1.0976.263±1.3512.917±1.1632.878±1.0840.000*

Table 1: Comparison of the antioxidant profile of the HIV patients in the six selected hospitals with their respective controls (

ControlST CHARLESPVIMSUTHPVABSUTHPVFMCUPVNAUTHPVFMCOPV
Urea22.72±3.48727.040±6.0470.000*25.926±6.1580.000*27.160±4.5900.000*26.416±5.7860.000*27.060±5.4670.000*26.850±5.0030.000*
Creat.0.682±0.1010.685±0.1200.7880.671±0.1250.7880.663±0.1120.4360.663±0.1180.3830.664±0.1190.7880.663±0.1180.788
Na+137.740±3.212136.780±2.3670.09136.740±2.5150.113134.51±7.8600.044*136.800±3.1360.25136.740±2.7460.063136.800±3.1360.055
K+3.896±0.4573.836±0.3990.093.830±0.4380.0923.864±4.1880.0573.878±0.3930.1623.872±0.4160.053.778±0.3930.056
Cl-101.220±2.112100.800±2.2030.1100.920±2.6320.1101.060±2.6210.061101.240±2.52700.06100.900±2.71900.099101.300±2.530.11
HCO-323.560±3.55922.600±3.5910.05323.620±3.1010.07523.960±3.1030.10124.000±3.2320.1423.700±2.9770.11524.120±3.1010.075

Table 2: Comparison of the renal function profile of the HIV patients in the six selected hospitals with their respective control

PV: Value; *: Significant Table 2: Comparison of the renal function profile of the HIV patients in the six selected hospitals with their respective controls (n=50) X ± SD.

ControlST CharlesIMSUTHABSUTHFMCUNAUTHFMCOP Value
Total Chol143.880±20.028136.440±16.738126.440±10.738130.660±13.536126.460±10.232128.340±8.034128.800±7.5860.000*
Triglyceride108.640±17.501120.020±17.234122.020±17.234129.220±8.883122.680±16.391124.460±12.030129.920±8.7890.000*
HDL42.740±5.97833.040±5.08231.040±5.08231.240±4.38232.740±5.55730.400±5.44232.360±5.4420.000*
LDL78.080±17.05762.860±8.63067.860±8.63071.300±8.76069.200±9.54472.380±10.49370.820±9.5500.000*
ControlST CharlesIMSUTHABSUTHFMCUNAUTHFMCOP Value
VIT C1.44±0.1850.797±0.1280.810±0.1330.746±0.8180.785±0.1250.769±0.1720.803±0.1740.000*
VIT E1.226±0.2740.790±0.1750.789±0.2410.761±0.1990.786±0.2260.807±0.1780.776±0.1620.000*
GPX32.274±9.32127.254±8.13026.936±7.98225.776±6.99527.288±8.15427.688±7.92825.850±6.8030.000*
UA4.440±0.9255.256±0.8065.240±0.8425.292±0.7985.318±0.7655.268±0.7655.224±1.0300.000*
MDA1.680±0.7991.889±0.7452.138±0.9421.741±0.7601.943±0.7881.959±0.8021.637±0.6930.000*

Table 3: Comparison of lipid profile of HIV patients in the six selected hospitals with their respective controls (n=50) X ± SD.

ControlST CharlesPVIMSUTHPVABSUTHPVFMCUPVNAUTHPVFMCOPV
Urea22.720±3.48719.760±2.6220.000*20.020±3.1710.000*19.620±4.4480.000*20.060±2.3790.000*19.400±2.8060.000*18.940±2.4610.000*
Creat.0.682±0.1010.686±0.0910.7880.693±0.0960.7880.688±0.0920.4360.692±0.0980.3830.691±0.0920.7880.691±0.0940.788
Na+137.740±3.212139.780±3.6210.000*139.78±3.3380.000*139.480±3.7400.044*149.270±2.4170.000*139.640±3.6350.000*139.760±3.7510.049*
K+3.896±0.4572.986±0.5170.000*3.026±0.5200.000*3.379±0.3880.016*3.152±0.4360.000*3.096±0.4570.463.018±0.5170.000*
Cl-101.220±2.112103.920±3.7620.000*104.07±3.7640.000*104.360±3.5950.000*102.659±3.1170.052103.240±3.7710.00*103.540±3.7370.000*
HCO-323.560±3.55919.520±2.5000.000*20.680±3.0890.000*20.420±2.2500.000*17.825±3.4690.000*19.600±2.7250.000*19.360±2.2560.000*

Table 4: Comparison of the renal function profile of PTB patients in the six selected hospitals with their respective controls (n

ControlST CHARLESIMSUTHABSUTHFMCUNAUTHFMCOP Value
Total Chol143.88±20.028125.760±8.807119.080±11.710121.100±7.619128.820±8.719127.730±18.033122.400±10.0850.000*
Triglyceride108.640±17.501102.84±17.791102.64±14.832105.940±17.106102.700±15.391101.520±17.46297.720±17.0790.000*
HDL42.740±5.97833.060±4.73131.760±4.38732.000±4.57533.340±4.56932.462±5.94633.880±5.7230.000*
LDL78.080±17.05771.960±8.22366.260±9.31968.040±6.04774.540±8.41076.160±10.61470.300±6.5620.000*

Table 5: Comparison of lipid profile of the PTB patients in the six selected hospitals with their respective controls (n=50) X ±

Discussion

Tuberculosis (TB) and HIV have been closely linked since the emergence of AIDS. Worldwide, TB is the most common opportunistic infection affecting HIV-seropositive individuals. It remains the most common cause of death in patients with AIDS and HIV infection has contributed to a significant increase in the worldwide incidence of TB [13].

The analysis however showed decline in the antioxidants. Deficiency of antioxidants was indicated in the results of antioxidants that were conducted on the HIV and TB patients as all of the GPX, Vit C and Vit E were reduced when compared to the control. This deficiency of antioxidants might markedly increase oxidative stress which possibly might adversely affect the immune system [14]. This study also showed increased lipid peroxidation measured by MDA concentrations both in HIV and TB seropositive patients. The possibility of counteracting oxidative stress by a pool of proper antioxidants plus an appropriate diet mainly in patients whose blood antioxidant deficiencies can be easily rebalanced may have real health benefit and represent a promising way of inhibiting the progression of disease. Moreso, supplements of vitamin E and C suggestingly may reduce oxidative stress in HIV and produce a trend towards a reduction in viral load and so can be pooled and be given a clinical trial especially in HIV-infected persons who cannot afford new combination therapies [15].

Renal function parameters were mostly normal in HIV seropositive patients but mostly were low in PTB positive patients for potassium and bicarbonate whereas sodium and chloride were elevated. It showed in this study that patients with PTB should have their electrolytes monitored as it is an important aspect of TB management [16]. The pattern of electrolytes, urea and creatinine observed in this study of pulmonary tuberculosis and HIV patients will definitely be of help in the differential diagnosis and in the understanding of the pathophysiology of the two disease conditions [17]. Besides, it was discovered in this study that PTB & HIV affected those in their productive years of 18-47 age range and males are more affected than females by PTB while females are more affected than males by HIV [18, 19].

Conclusion

Therefore, to manage HIV and TB patients efficiently and effectively, important biochemical analyses should be conducted regularly and more concerted effort should be made by all and sundry, government, non-governmental organizations and individuals to step up interventions that will bring TB and HIV spread to a halt in these states.

References

  1. Global HIV/AIDS Response (2011) Epidemic update and health sector progress towards Universal Access Progress Report. 3. World Health Organization (1997). Treatment of Tuberculosis: Guidelines for National Programmes 2nd (Edn.), Geneva.
  2. World Health Organization (2006) WHO case definitions of HIV for Surveillance and revised Clinical Staging and Immunological Classification.
  3. WHO Global Tuberculosis controls (2008). Epidemiology of tuberculosis WHO/HTM/TB. 393 Geneva.
  4. UNAIDS (2015) Epidemiological slides – How AIDS changed everything report.
  5. World Health Organization (2008) Global Tuberculosis Control: Surveillance, Planning, Finance.
  6. Nasiell M, Roger V, Naiell K, Enstad, Vogel B, et al. (l972) Cytologic findings indicating Pulmonary Tuberculosis: The diagnostic significance of epithelioid cells and Langhans giant cells found in sputum or bronchial secretions. ActaCytol 16(2): 146-151.
  7. Ogunro PS, Ogungbamigbe TO, Ajala MO, Egbewale BE (2005) Total antioxidant Status and lipid Peroxidation in HIV-1 infected patients in rural area of South Western Nigeria. Afri J Med Medic Sci 34 (3): 221-225.
  8. Halliwell B, Gutteridge JC (1995) The definition and measurement of antioxidants in Biological system. Free Radic Biol med 18(1): 125-126.
  9. Baker FJ, Silverton RE (1985) Introduction to Medical Laboratory Technology: Cytological techniques. 6th (Edn.), Butterworths and CO Publishers, pp: 235-240.
  10. Satoh K (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica chemical Acta 90(1): 37-43.
  11. Tietz (2006) Determination of Plasma Vitamin C. Clinical Guide to Laboratory tests. 2nd (Edn.), WB Squnders Company. Philadelphia, pp: 554-556.
  12. Forrester RL, Wataji LJ, Silverman DA, Pierre KJ (1976) Enzymatic method for determination of Co2 in serum. Clin Chem22(2): 243-245.
  13. WHO Global Tuberculosis Report (2010) WHO 2010 Multidrug and extensively drug- resistant TB M/XDR – TB, WHO 2010.
  14. Pasupathi P, Ramachandran T, Sindhu PJ, Saravanan G, Bakthavathsalam G (2009) Enhanced Oxidative Stress Markers and Antioxidant Imbalance in HIV infection and AIDS patients. J Scientific Research 1 (2): 370-380.
  15. Alan MD, Hu YJ, Mausur DB (2001) Glutathione peroxidase and viral replication: implications for viral evolution and chemoprevention. Biofactors 14(4): 205- 210.
  16. Adebimpe WO, Fayemi AO, Hassan AW, Akeem AD (2015) Evaluation of electrolyte imbalance among tuberculosis patients in Southwestern Nigeria. AJME 10: 3.
  17. Olaniyan MF, Adesoji AA (2004) Comparative study of plasma electrolytes (Na, K, CL, and HCO3) and urea levels in HIV/AIDS and pulmonary tuberculosis infected subjects. Biokmistri 16 (1): 29-36.
  18. Neyrolles O, Quintana-Murci L (2009) Sexual Inequality in Tuberculosis. PloS Med 6(12): e1000199.
  19. Global HIV/AIDS Epidemic (2015) Overview 7: 31.

Cite this article

BibTeX
APA
RIS
@article{cletus2021,
  title   = {Biochemical Studies of Tuberclosis and HIV Cases in Parts of Abia, Anambra and Imo States},
  author  = {Cletus OE, Nwachukwu NC, Elendu CO and Johnkennedy N},
  journal = {Medical Journal of Clinical Trials & Case Studies},
  year    = {2021},
  volume  = {5},
  number  = {3},
  doi     = {10.23880/mjccs-16000288}
}
Cletus OE, Nwachukwu NC, Elendu CO and Johnkennedy N (2021). Biochemical Studies of Tuberclosis and HIV Cases in Parts of Abia, Anambra and Imo States. Medical Journal of Clinical Trials & Case Studies, 5(3). https://doi.org/10.23880/mjccs-16000288
TY  - JOUR
TI  - Biochemical Studies of Tuberclosis and HIV Cases in Parts of Abia, Anambra and Imo States
AU  - Cletus OE, Nwachukwu NC, Elendu CO and Johnkennedy N
JO  - Medical Journal of Clinical Trials & Case Studies
PY  - 2021
VL  - 5
IS  - 3
DO  - 10.23880/mjccs-16000288
ER  -